Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

11 results
Display

Cardiovascular Risks of Androgen Deprivation Therapy for Prostate Cancer

Corona G, Filippi S, Bianchi N, Dicuio M, Rastrelli G, Concetti S, Sforza A, Maggi M

Androgen deprivation therapy (ADT) is the gold standard treatment in patients with locally advanced or metastatic prostate cancer (PC). Emerging evidence has documented a tight association between ADT and body...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Correlation of Androgen Deprivation Therapy with Cognitive Dysfunction in Patients with Prostate Cancer: A Nationwide Population-Based Study Using the National Health Insurance Service Database

Tae BS, Jeon BJ, Shin SH, Choi H, Bae JH, Park JY

PURPOSE: The purpose of this study was to evaluate the association of androgen deprivation therapy (ADT) with cognitive dysfunction. MATERIALS AND METHODS: Using the National Health Insurance Service database of the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of zoledronic acid in older prostate cancer patients undergoing androgen deprivation therapy

Kojima I, Naito Y, Yamamoto A, Terashima , Sho N, Nagayama J, Okada Y, Nagai T

OBJECTIVES: The purpose of this study is to evaluate the efficacy of annual zoledronic acid treatment in Japanese patients with nonmetastatic prostate cancer during androgen deprivation therapy (ADT). METHODS: This is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Impact of Early Salvage Androgen Deprivation Therapy in Localized Prostate Cancer after Radical Prostatectomy: A Propensity Score Matched Analysis

Park JW, Jang WS, Koh DH, Ham WS, Rha KH, Hong SJ, Choi YD

PURPOSE: Androgen deprivation therapy (ADT) is used as a salvage treatment for men with biochemical recurrence (BCR) of prostate cancer (PCa) following initial radical prostatectomy (RP). The optimal time at...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-Lasting Antiandrogen Withdrawal Syndrome in Castration-Resistant Prostate Cancer: Three Cases With Complete Response

Kim SJ, Ryu JH, Kim YB, Jung TY

This is a case report of 3 patients who had a dramatic and long-term complete response after antiandrogen withdrawal. All 3 patients were diagnosed with advanced or metastatic prostate cancer...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Factors associated with testosterone recovery after androgen deprivation therapy in patients with prostate cancer

Nam W, Choi SY, Yoo SJ, Ryu J, Lee J, Kyung YS, Han JH, You D, Jeong IG, Hong JH, Ahn H, Kim CS

PURPOSE: We investigated factors affecting testosterone recovery after androgen deprivation therapy (ADT) withdrawal in patients with prostate cancer. MATERIALS AND METHODS: The medical records of patients who underwent radical prostatectomy with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Multimodal therapy for locally advanced prostate cancer: the roles of radiotherapy, androgen deprivation therapy, and their combination

Lee SU, Cho KH

Locally advanced prostate cancer (LAPC) is defined as histologically proven T3–4 prostatic adenocarcinoma. In this review, we define the individual roles of radiotherapy (RT), short-term (ST-) and long-term (LT-) androgen...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Outcomes of Continuous Addition of Androgen Deprivation Therapy During Docetaxel Chemotherapy for Patients With Castration-Resistant Prostate Cancer

Lee DH, Kim JH, Seo WI, Nam JK, Kim TN, Oh CK, Kim SD, Park SW, Chung JS, Park SH, Lee W, Sung GT, Chung MK, Chung JI

PURPOSE: This study compared the oncologic results of docetaxel chemotherapy (DOC) in castration-resistant prostate cancer (CRPC) according to continuous addition of androgen deprivation therapy (ADT) during chemotherapy. MATERIALS AND METHODS: We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Influence of Androgen Deprivation Therapy on Prostate Size and Voiding Symptoms in Prostate Cancer Patients in Korea

Choi H, Chung H, Park JY, Lee JG, Bae JH

PURPOSE: The goal of this study is to investigate the effects of androgen deprivation therapy (ADT) on total prostate volume and lower urinary tract symptoms (LUTS). METHODS: Between January 2007 and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cause of Death in Korean Men with Prostate Cancer: an Analysis of Time Trends in a Nationwide Cohort

Park J, Suh B, Shin DW, Hong JH, Ahn H

Despite rapid increase in incidence of prostate cancer (PC) and PC survivors, there are few studies regarding competing causes of death and time trends in Asian population. We conducted a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Outcome of postoperative radiotherapy following radical prostatectomy: a single institutional experience

Lee SW, Hwang TK, Hong SH, Lee JY, Chung MJ, Jeong SM, Kim SH, Lee JH, Jang HS, Yoon SC

PURPOSE: This single institutional study is aimed to observe the outcome of patients who received postoperative radiotherapy after radical prostatectomy. MATERIALS AND METHODS: A total of 59 men with histologically identified...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr